Why is "Risperidone" trending?

Search Interest Perspective

• Risperidone reduces individualized morphometric similarity deviation in schizophrenia and associates with cortical transcriptomic patterns - Nature
• Risperdal (Risperidone) Side Effects: Common and Rare - Verywell Mind
• Pharmacogenomics of risperidone in autism spectrum disorder: a minireview - Frontiers
• Low Oxygen Saturation During Risperidone Therapy: A Multispecialty Approach - Cureus
• FDA Approves Risperidone Extended-Release Injectable Suspension - Psychiatric Times
• Uzedy: FDA Approves Once-a-Month Subcutaneous Injectable Risperidone for Bipolar I Disorder - WebMD
• Risperidone High Blood Sugar | Can Medications Lower Blood Sugar | Should Dads Like Me Panic Over Silent Symptoms Of Prediabetes Most People Ignore? - Fathom Journal
• Amneal’s Injectable Extended-Release Suspension of Risperidone Receives FDA Approval to Treat Schizophrenia - Pharmacy Times
• Risperidone Use in Dementia Linked to Increased Stroke Risk Regardless of CVD History - Medscape
• 165,000 dementia patients reveal hidden stroke risk from common drug - ScienceDaily
• Dementia drug raises stroke risk — even in 'low-risk' patients, UK study shows - Brunel University
• FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder - GlobeNewswire
• Widely Used Dementia Drug Raises Stroke Risk in All Patients - SciTechDaily
• FDA Approves Risperidone Extended-Release Injectable for Bipolar I Disorder - HCPLive
• Once-Weekly Oral Risperidone Shows Promise in Schizophrenia Treatment - Technology Networks
• Extended-Release Risperidone Injection Receives FDA Approval - Conexiant
• Neuroimaging Insights Into Risperidone Effects in Schizophrenia - Physician's Weekly
• Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension - Yahoo Finance
• Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity, the First Product from its Nanomi's Long-Acting Injectable Platform - PR Newswire
• Risk of major adverse cardiovascular events with aripiprazole versus olanzapine, quetiapine, and risperidone in severe mental illness: a target trial emulation - Nature
• Repurposing risperidone as an anti-angiogenic agent for triple-negative breast cancer: a computational to in ovo investigation - Frontiers
• Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere™ - Lupin | Press Release - lupin.com
• Weekly risperidone capsule delivers consistent drug levels for schizophrenia patients - News-Medical
• Decreased low-frequency amplitude of the right caudate nucleus in patients with chronic schizophrenia treated with risperidone combined with clozapine - Frontiers
• Risperidone OK'd for Bipolar I; Stockholm Syndrome Inspo Dies; Bella Hadid's Battle - MedPage Today
• MRI-based insights into brain structural and functional alterations in schizophrenia treated with risperidone - Frontiers
• Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere™ - lupin.com
• FDA Approves Expanded Indication for Risperidone Extended-Release Injectable to Treat Bipolar I Disorder - Pharmacy Times
• FDA Approves Uzedy Once-Monthly Extended Release Injectable Suspension for Bipolar I Disorder - Psychiatric Times
• Figure2 - CMAJ
• FDA Approves Risperidone Injection for Bipolar I Disorder in Adults - Drug Topics
• Antipsychotic Meds Not Effective for Combat PTSD - abcnews.com
• Teva and Medincell’s Risperidone LAI Approved in Canada as LONGAVO® - Business Wire
• Risperidone in dementia raises stroke risk, even in ‘low-risk’ patients - Pulse Today
• Comparison of Antipsychotics in the Treatment of COVID-19-Induced First-Episode Psychosis: A Review of Case Studies - Cureus
• Relapse Risk after Discontinuation of Risperidone in Alzheimer's Disease - NEJM
• Hepatotoxicity to Risperidone - Psychiatrist.com
• Risperidone Induced Hyperprolactinemia: From Basic to Clinical Studies - Frontiers
• A 26-Year Follow-up of a Woman With 5 Consecutive Children Exposed to Risperidone During Pregnancy and Breastfeeding - Psychiatrist.com
• Risperidone use in children with autism carries heavy risks - The Transmitter
• FDA clears Lupin bipolar disorder therapy Risperidone with 180-day exclusivity - ET Pharma
• Pathophysiology and management of risperidone-induced sialorrhea: case report - Frontiers
• Memantine abrogates testicular dysfunction induced by risperidone in rats with a potential role of ERK1/2-Nrf2-caspase-3 signaling pathway - Nature
• Antipsychotic prescribing in dementia does not follow NICE guidance, study shows - The Pharmaceutical Journal
• A Comparison of Risperidone and Haloperidol for the Prevention of Relapse in Patients with Schizophrenia - NEJM
• Unusually High Levels of Prolactin With Risperidone - Psychiatrist.com
• Risperidone elevates stroke risk in people with dementia having prior history of CVD: Study - Medical Dialogues
• Lupin launches generic injection in US with 180-day exclusivity - ET Pharma
• lupin has received approval from usfda for its anda for risperidone - ICICI Direct
• Lupin wins USFDA nod for Risperidone for extended-release injectable suspension for schizophrenia - Medical Dialogues
• Effects of risperidone/paliperidone versus placebo on cognitive functioning over the first 6 months of treatment for psychotic disorder: secondary analysis of a triple-blind randomised clinical trial | Translational Psychiatry - Nature
• Treating schizophrenia with Risperdal: How effective is it? - Medical News Today
• Lupin gets USFDA nod for generic risperidone extended-release injectable suspension - The Economic Times
• Lupin receives US FDA approval for Risperidone long-acting Injectable - Express Pharma
• Effects of cannabidiol on vacuous chewing movements, plasma glucose and oxidative stress indices in rats administered high dose risperidone - Nature
• The 7 Drugs, Foods That May Cause Risperidone Interactions - GoodRx
• Metabolic biomarkers of risperidone-induced weight gain in drug-naïve patients with schizophrenia - Frontiers
• Investigation of Risperidone Treatment Associated With Enhanced Brain Activity in Patients Who Stutter - Frontiers
• Weekly Oral Risperidone Found Effective and Safe for Schizophrenia in Phase III Trial - Medical Dialogues
• Combination Therapy With Risperidone and High-Dose Melatonin Is Effective Despite Reversible Side Effects Including Breast Budding - Cureus
• Lupin launches Risperidone extended-release injectable suspension in the U.S. with 180-day CGT exclusivity - Express Pharma
• Clinical research: Risperidone boosts milk hormone - The Transmitter
• Converting From Intramuscular to Oral Risperidone in a Nursing Home Resident - Psychiatrist.com
• Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone - Nature
• Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial - The Lancet
• Weekly schizophrenia pill produces promising results in final-stage trial - New Atlas
• Scientists identify source of weight gain from antipsychotics: Newsroom - UT Southwestern Medical Center
• Lupin launches generic Risperdal Consta - Drug Store News
• Antipsychotic raises stroke risk in dementia patients - NR Times
• Long-Acting Risperidone and Oral Antipsychotics in Unstable Schizophrenia - NEJM
• Olanzapine, risperidone and ziprasidone differently affect lysosomal function and autophagy, reflecting their different metabolic risk in patients - Nature
• Exploring High-Dose Olanzapine for Psychosis in an Adolescent With Treatment-Resistant Schizophrenia - Cureus
• The atypical antipsychotic risperidone targets hypothalamic melanocortin 4 receptors to cause weight gain - Rockefeller University Press
• Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial | Molecular Psychiatry - Nature
• Weekly risperidone achieves similar drug levels as daily dose in phase 3 trial - Healio
• Risperidone-Induced Urinary Incontinence in Schizoaffective Disorder: A Case Report - Cureus
• Antipsychotic medication for behaviors that challenge in individuals with intellectual disabilities: a clinically informed review - Frontiers
• Updated rationale for the initial antipsychotic selection for patients with schizophrenia - Nature
• Data show ‘spiralling’ antipsychotic price increases of up to 1,200% in past five years - The Pharmaceutical Journal
• BMS's Cobenfy disappoints as add-on therapy in schizophrenia study - FirstWord Pharma
• Acute Medicine & Surgery | JAAM Journal - Wiley Online Library
• An antipsychotic proves effective in treating schizophrenia when taken orally weekly rather than daily - Science Media Centre España
• Risperidone-Induced Hypothermia in a Cerebral Palsy Patient: A Case Report and Literature Review - Cureus
• Risperidone for Autism: Does it Work? - Autism Parenting Magazine
• Oculogyric Crisis in the Setting of Low Dose Risperidone and Benztropine Mesylate Use in a Patient With Schizophrenia: A Case Report and Review of Literature - Cureus
• Risperidone-Associated Neuroleptic Malignant Syndrome in an Inpatient With Schizophrenia, With Successful Rechallenge and 3 Year Follow-Up - Frontiers
• Risperidone-induced hypersexuality - Cambridge University Press & Assessment
• Clozapine Alone versus Clozapine and Risperidone with Refractory Schizophrenia - NEJM
• Clinical challenges in the dosing and titration of cariprazine - Frontiers
• Risk of weight gain for specific antipsychotic drugs: a meta-analysis - Nature
• Risperidone-induced weight gain and reduced locomotor activity in juvenile female rats: The role of histaminergic and NPY pathways - ScienceDirect.com
• The Relief of Leukocytopenia Within 1 Month After Switching Risperidone to Amisulpride - Psychiatry Online
• Predicting individual-level stroke risk associated with risperidone use in dementia using cardiovascular disease history: matched UK population based cohort study - Wiley
• Lupin Gains on USFDA Nod for Risperidone Injectable - HDFC Sky
• Eugenics, Lobotomy, Risperidone: "Science" Gone Awry - Mad In America
• A Machine Learning Model to Predict Risperidone Active Moiety Concentration Based on Initial Therapeutic Drug Monitoring - Frontiers
• FDA Approves Risperidone Extended-Release Injectable Suspension for Schizophrenia - Pharmacy Times
• Omega-3 fatty acid deficiency augments risperidone-induced hepatic steatosis in rats: Positive association with stearoyl-CoA desaturase - ScienceDirect.com
• Association of telomere length and mitochondrial DNA copy number with risperidone treatment response in first-episode antipsychotic-naïve schizophrenia - Nature
• From Psychiatric Care to Dermatologic Dilemmas: A Case Report of Risperidone-Induced Bullous Pemphigoid - Cureus